InvestorsObserver
×
News Home

Analyst Rating: Will SpringWorks Therapeutics Inc (SWTX) Stock Beat the Market?

Friday, May 20, 2022 02:09 PM | InvestorsObserver Analysts

Mentioned in this article

Analyst Rating: Will SpringWorks Therapeutics Inc (SWTX) Stock Beat the Market?

Analysts who follow SpringWorks Therapeutics Inc (SWTX) on average expect it to gain 206.44% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns SWTX an Analyst Ranking of 72, which means it ranks higher than 72 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 5
Wall Street analysts are rating SWTX a Strong Buy today. Find out what this means to you and get the rest of the rankings on SWTX!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With SpringWorks Therapeutics Inc Stock Today?

SpringWorks Therapeutics Inc (SWTX) stock is trading at $37.12 as of 2:07 PM on Friday, May 20, a rise of $1.70, or 4.8% from the previous closing price of $35.42. The stock has traded between $35.19 and $37.59 so far today. Volume today is 480,440 compared to average volume of 579,155. Click Here to get the full Stock Report for SpringWorks Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App